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Abstract
Candida albicans is a human fungal pathogen that causes millions of mucosal and life-threatening infections 
annually.  C. albicans initially interacts with epithelial cells, resulting in fungal recognition and the formation 
of hyphae.  Hypha formation is critical for host cell damage and immune activation, which are both driven 
by the secretion of Candidalysin, a recently discovered peptide toxin.  Epithelial activation leads to the 
production of inflammatory mediators that recruit innate immune cells including neutrophils, macrophages 
and innate Type 17 cells, which together work with epithelial cells to clear the fungal infection.  This review 
will focus on the recent discoveries that have advanced our understanding of C. albicans-epithelial 
interactions and the induction of mucosal innate immunity.
Introduction
Candida albicans is normally a harmless commensal organism within the normal microbiota in 
approximately half the world’s population.  In the commensal phase, C. albicans most likely resides in the 
mucus layer of mucosal surfaces. However, occasionally and under certain circumstances, C. albicans may 
encounter host cells directly, which may result in the attachment of the fungus to epithelial cells.  
Depending on the strain of C. albicans and the physiological and immune status of the host, this interaction 
event can lead to superficial overgrowth and epithelial invasion, followed by disease and immune 
activation.  C. albicans is the most prevalent Candida species causing infections in humans and is the 
causative agent of oral and vaginal candidiasis (e.g. thrush), giving rise to severe morbidity in millions of 
individuals worldwide.  Given that potentially fatal systemic infections can arise from breaches of the 
mucosal barrier (predominantly from the gut) it is of paramount importance to understand how C. albicans 
interacts with cells of the innate immune system and how this fungus is restricted to the mucosal surface in 
health.  Critical to this is an understanding of how epithelial cells are able to discriminate between harmless 
(commensal) and dangerous (pathogenic) C. albicans cells, which determines whether a mutually beneficial 
commensal relationship or immune activation takes place.
C. albicans interaction with epithelial cells: adhesion and invasion
Epithelial cells at mucosal surfaces are the first point of contact with C. albicans and constitute the first line 
of defence. Although fungal pathogenicity depends on the type of mucosal tissue, there are common 
virulence mechanisms and principles. C. albicans adhesion to epithelial cells is mediated through the 
interaction of fungal cell wall moieties and surface proteins with host receptors (Table 1).  C. albicans yeast 
cells are recognized by oral epithelial cells (in the TR146 cell line) and induce three signalling pathways 
within 15 min; the nuclear factor-kappaB (NF-κB) pathway, the phosphatidylinositol-4,5-bisphosphate 3-
kinase (Pi3K), and all three mitogen-activated protein kinase (MAPK) pathways (p38, JNK (c-Jun N-terminal 
kinase) and ERK1/2 (extracellular signal-regulated protein kinase)).  This results in the activation of the 
p65/p50 transcription factor via NF-κB, the c-Jun transcription factor via JNK and ERK1/2, and AKT (protein 
kinase B) and mTor (mammalian target of rapamycin) via Pi3K signaling [1,2].  Initial binding may constitute 
recognition of fungal cell wall mannans and β-glucans but this does not fully activate epithelial cells as 
proinflammatory cytokines were not induced [2].  Lack of activation by C. albicans cell wall polysaccharides 
was also found in skin keratinocytes [3], suggesting that fungal polysaccharides play a limited role in 
inducing epithelial/keratinocyte immune responses.  While many other yeast-associated secreted/cell-
surface proteins (e.g. Sap1-3/9/10, Als1/3/4/9, Mp65, Phr1, Iff4, Sun41, Pra1, Eap1, Utr2 and Ecm33), cell 
wall processing proteins (e.g. Big1, Mnt1/2, Mnn9), and protein trafficking/ vesicle transport proteins (e.g. 
Vps11) are thought to promote epithelial adhesion, this is likely to be via indirect mechanisms given that 
these proteins possess complex, multi-factorial functions that contribute to cell wall integrity and hypha 
formation [4-7]. 
Adhesion of C. albicans to an epithelial cell is a strong inducer of hypha formation.  The formation 
of hyphae occurs within 30 – 60 min and this is accompanied by the expression of hypha-associated 
proteins, which are known to possess critical roles in adhesion, invasion, damage induction and immune 
activation/evasion.  The two key hyphal proteins that promote epithelial adhesion are Hwp1 (hyphal wall 
protein 1) [8] and Als3 (agglutinin-like sequence 3) [9,10].  Hwp1 is highly expressed in human oral 
infections [11] and acts as a substrate for epithelial transglutaminases, enabling strong covalent links with 
other epithelial proteins [12].  Als3 is both an adhesin and an invasin, and together with Ssa1 (heat shock 
protein) promotes the endocytosis of C. albicans into epithelial cells via E-cadherin [13-15] and the 
EGFR/Her2 (epidermal growth factor receptor/human epidermal growth factor 2) complex [16]. 
Endocytosis is an entirely host driven process and does not require viable hyphae [17].  Other pathways 
that promote C. albicans endocytosis include the PDGF BB (platelet-derived growth factor BB) and NEDD9 
(neural precursor-cell-expressed developmentally downregulated protein 9) pathways, which both require 
hypha formation and Als3 expression [18•].  However, despite possessing adhesion/invasin activities, Als3 
does not directly induce epithelial cell damage or cytokine production [19]. The AhR (aryl hydrocarbon 
receptor) also contributes to the endocytosis of C. albicans via Src family kinase phosphorylation of EGFR, 
but AhR is not involved in epithelial damage or cytokine induction by C. albicans and it is unknown how AhR 
is activated [20•].  Currently, the level of redundancy between these different pathways (E-cadherin, 
EGFR/Her2, AhR, PDGF BB and NEDD9) and how they communicate to promote C. albicans endocytosis is 
unclear.  It is important to note that induced endocytosis is not the only invasion route of C. albicans.  
Indeed, active penetration, which does not require host activities, seems to be the dominant invasion route 
depending on the type of epithelial cell [21].
Epithelial damage and immune activation by Candidalysin 
While C. albicans adhesion and invasion leads to fungal recognition and signal pathway activation, 
surprisingly this does not translate into epithelial damage or innate immune activation [2,17].  Recently, it 
was discovered that C. albicans hyphae induce both epithelial damage and innate immunity through the 
secretion of a cytolytic peptide toxin called Candidalysin, which is encoded by the hypha-associated ECE1 
gene [22••].  Candidalysin is an amphipathic peptide that adopts an α-helical structure and is the first 
peptide toxin to be identified in any human fungal pathogen.  In oral epithelial cells, Candidalysin induces 
calcium ion influx and lactate dehydrogenase (LDH) release, which are characteristics of cell damage and 
membrane destabilization (Figure 1).  Notably, C. albicans mutants where the entire ECE1 gene or the 
Candidalysin-encoding region has been deleted, have full invasive potential in vitro but are incapable of 
inducing tissue damage or cytokine release, and are highly attenuated in a murine model of oropharyngeal 
candidiasis and a zebrafish swimbladder mucosal model [22••].
Candidalysin induces epithelial immunity predominantly via MAPK signalling, specifically (i) the p38 
pathway, resulting in the activation of the AP-1 transcription factor c-Fos, and (ii) the  ERK1/2 pathway, 
resulting in the activation of MKP1 (MAPK phosphatase 1) that regulates immune responses [22••].  
Together, these pathways lead to the production of pro-inflammatory cytokines including IL-1α/β, IL-6, GM-
CSF and G-CSF.  Importantly, p38/c-Fos and MKP1 is also activated in human vaginal epithelial cells [23] and 
by other hypha-forming Candida species [24].  Therefore, these signalling pathways may enable different 
mucosal tissues to detect fungal hyphae, thereby potentially identifying when certain Candida species have 
become pathogenic.  Notably, epithelial activation by Candidalysin is not mediated via C-type lectin 
receptors (CLRs) or Toll-like receptors (TLRs) [2], suggesting that epithelial cells utilise different sensing 
mechanisms than myeloid cells; whereby myeloid cells respond to C. albicans cell wall moieties (β-glucan 
and mannans) (see below) and epithelial cells respond to damage-inducing C. albicans through p38/c-
Fos/MKP1 by detecting Candidalysin activity [25-27].  Similar p38 activation has been observed in murine 
intestinal epithelial cells with bacterial pathogens (Citrobacter rodentium) [28] and in C. elegans (nematode 
worm) with C. albicans [29], indicating that p38 signalling may be a common epithelial mechanism for the 
detection of pathogenic microbes.
Innate immunity at mucosal surfaces: neutrophils and macrophages 
C. albicans, predominantly through Candidalysin activity, induces proinflammatory cytokines, chemokines 
and antimicrobial peptides (e.g.  IL-1α, IL-1, IL-8, G-CSF, GM-CSF, β-defensin 3, CCL20 and S100A8/9) from 
epithelial cells that are required for immune cell recruitment [2,22••,30].  The key myeloid cells that are 
initially recruited to the site of infection include neutrophils and macrophages (Figure 1).  These immune 
cells recognize C. albicans cell wall mannans and DNA via TLR2, 4 and 9, and fungal β-glucan via CLRs 
including Dectin-1/-2, DC-SIGN or Mincle [31-33].  Activation of TLRs and CLRs leads to the induction of NF-
B, MAPK and Syk signaling and the production of pro-inflammatory cytokines and further downstream 
immune effector functions.  Nod-like receptors (NLRs) can also be activated by danger signals or 
internalized fungal compounds and this leads to inflammasome activation and the secretion of IL-1β and IL-
18, which help protect against superficial and disseminated C. albicans infection [34].
Upon C. albicans infection, neutrophils are rapidly recruited to the site of entry.  Even without 
physical contact to invading hyphae, neutrophils respond to epithelial derived chemokines and growth 
factors and release TNFα, which in turn triggers a protective effect in epithelial cells via the upregulation of 
TLR4 [35].  Neutrophils also inhibit hyphal formation without direct contact [36,37].  Neutrophils can also 
be recruited by responding directly to C. albicans-derived factors such as the secreted aspartic proteases 
(Saps) [38•].  Furthermore, neutrophils phagocytose (e.g. via CLRs) and kill C. albicans yeast cells and short 
hyphae intracellularly predominantly via oxidative burst mechanisms.  C. albicans hyphae that are too large 
to be phagocytosed are either growth-inhibited or killed extracellularly through the formation of neutrophil 
extracellular traps (NETs or NETosis), via the release of granule enzymes and through secretion of 
antimicrobial peptides such as calprotectin [39,40,41•].  Indeed, the zinc binding properties of calprotectin 
inhibits C. albicans growth during NET formation [40].  C. albicans hyphae trigger NETosis more effectively 
and rapidly than yeast cells, but both morphologies can induce NETs via autophagy and oxidative 
mechanisms [42•].  Reactive oxygen species [43], fibronectin [44] and Dectin-1 signaling [45] have also 
been implicated in NET formation. However, the role of Dectin-1 is controversial as other studies indicate 
that NET release by β-glucan is mediated via complement receptor 3 (CD11b/CD18) and not Dectin-1 [44].
Macrophages are also recruited to the site of infection and ingest non-opsonized C. albicans after 
recognition by TLRs and CLRs [47].  While macrophages phagocytose and kill C. albicans intracellularly in the 
phagolysosome through oxidative and nitrosative mechanisms, their activity and efficiency of killing is 
lower than that of neutrophils.  Thus, C. albicans is readily able to survive within and escape from 
macrophages in vitro [48] and macrophages play a more minor role in vivo during murine disseminated 
infections [32,34].  Macrophages also recognize C. albicans via intracellular NLRs, which activates the NLRP3 
inflammasome, leading to production of pro-inflammatory IL-1β and IL-18 as well as pyroptotic host cell 
death [49,50].  Although immune cell death was originally thought to be hypha-dependent, hypha-
independent triggers of pyroptosis have also been described [51,52•].  Therefore, ﬁlamentation alone may 
not be sufﬁcient to trigger NLRP3 inﬂammasome-mediated pyroptosis [52•,53].   Intracellular hypha 
formation is driven by active alkalinization of the phagosome [54] and causes macrophage cell death by at 
least two different mechanisms: pyroptosis and physical piercing of the macrophage membrane [49,50,54].  
Notably, NLRP3 inﬂammasome activation is not necessarily coupled with pyroptosis and the fungal trigger 
that activates the inflammasome still remains unknown. Finally, while inflammasome activation can lead to 
IL-1β and IL-18 production, IL-1β has been implicated with Th17 responses whereas IL-18 appears to 
promote Th1 activity [55].
Innate immunity at mucosal surfaces: innate Type 17 cells
A key insight into requirements for host defense against mucosal candidiasis came from the recognition 
that mice lacking the IL-17 receptor or its key downstream signaling adaptor Act1 are highly susceptible to 
oropharyngeal candidiasis (OPC) [30,56,57].  Even more strikingly, when humans were subsequently 
identified with loss-of-function mutations in the same genes, their dominant disease susceptibility was 
chronic mucocutaneous candidiasis (CMC) [58,59,60••].  IL-17 is the eponymous cytokine of the Th17 
lineage, and a common misconception is that this cytokine functions mainly in the adaptive immune 
response.  However, a variety of innate cells of lymphoid origin produce IL-17, including -T, natural killer T 
(NKT), innate lymphoid cell type 3 (ILC3) and TCR+ ‘natural’ Th17 cells (nTh17) [61].  In the context of OPC, 
IL-17 is produced mainly by -T and nTh17 cells, and mice lacking a TCR (e.g., Rag1-/- or IL-7R-/- mice) are 
highly susceptible to infection [62].  Although ILC3s have also been reported in this context [63], Rag1-/- 
mice have ILC3 cells but still show the same high susceptibility to OPC as IL-17R-deficient mice [62].  The 
role of neutrophils in producing IL-17 is controversial, but data in the murine OPC model argues against 
neutrophils as a source of this cytokine [64].
Surprisingly, activation of innate Type 17 cells appears to be quite distinct from activation of 
adaptive Type 17 immunity.  A Dectin-1-Syk-CARD9 pathway was shown to be important for activating 
immunity to systemic candidiasis [65].  Consistently, CARD9 is essential for the adaptive Th17 recall 
response in oral candidiasis.  However, this adaptor was largely dispensable for induction of the acute 
innate IL-17 response [66], a finding that was also recently verified for Dectin-1 and TLR2 (A Verma et al., 
unpublished).  This new study finds that Candidalysin production by C. albicans hyphae is the triggering 
factor for innate IL-17 production in the murine model of OPC (Figure 1).  Mice infected with ECE1-deficient 
strains show only minimal induction of IL-17 or activation of nTh17 cell production of this cytokine.  
Additionally, IL-1R signaling is required for activation of the innate Type 17 response, with contributions 
from both hematopoietic and non-hematopoietic compartments (A Verma et al., unpublished).  A vital role 
for IL-1 in defense against OPC was shown previously in studies of the inflammasome in mouse OPC [67] 
and was recently verified in contributing to neutrophil activation in this setting [68]. Collectively, these data 
indicate that the early, innate response to C. albicans in the oral mucosa depends on sensing of tissue 
damage through Candidalysin, and not simply the presence of -glucan components revealed upon fungal 
filamentation.
Although the IL-17 receptor is expressed ubiquitously, we found that the essential responder cell in 
the context of oral candidiasis is the superficial oral epithelial cell [69•].  Mice with a conditional deletion of 
the IL-17 receptor in Keratin 13+ cells (including oral and buccal epithelial cells, but not skin, gut or other 
tissues) show a similar fungal susceptibility as mice with a full knockout of this receptor.  Moreover, gene 
pathway signatures induced in the oral mucosa during acute infection were highly conserved with genes 
induced by C. albicans and IL-17 in human oral keratinocytes [69].  
The anti-fungal functions of IL-17 are multi-fold.  First, IL-17 is a potent activator of the neutrophil 
response, which it triggers by inducing expression of neutrophil-recruiting chemokines and cytokines such 
as G-CSF, CXCL1/2 and 5 in oral tissue [30].  It should be noted that the extent to which IL-17 drives 
neutrophil signals may be variable [30,64,70].  Second, IL-17 potently induces anti-microbial peptides 
(AMPs), particularly -defensins-1 and -3.  Mice lacking these defensins show markedly increased 
susceptibility to OPC [30,69•,71].  IL-17 may also act on salivary gland cells, contributing to the production 
of antifungal AMPs such as histatins [72,73].  The combined action of IL-17 signaling promotes effective, 
non-redundant host defense to mucosal candidiasis.
As noted above, several human kindreds were identified with inherited mutations in the IL-17 
receptor signaling pathway that cause CMC [58-60].  Additionally, other gene defects that predispose to 
CMC are associated with defective IL-17 production or function, including mutations in STAT3 (Hyper-IgE 
Syndrome, HIES), STAT1 and AIRE (APECED) [74].  In the latter case, neutralizing antibodies against Type 17 
cytokines are found in affected patients, raising the possibility that disease is associated with reduced IL-17 
signaling.  Of course, in all these cases, IL-17 is likely produced by both innate cells and conventional 
(adaptive) Th17 cells.  In this regard, HIV patients with low CD4 T cells counts are highly prone to OPC, and 
this has been particularly associated with Th17 loss [75].  Finally, in 2016 the first biologic drugs 
(Secukinumab, Ixekizumab) targeting IL-17 (specifically, IL-17A and the IL-17A/F heterodimer) directly came 
to the market to treat psoriasis, a strongly IL-17-driven autoimmune disease [76].  Surprisingly, the 
incidence of OPC is quite low, in the range of 4-8% of patients [77].  This may simply mean that blockade is 
incomplete, due either to dose effects or access of anti-IL-17 antibodies to the oral mucosal tissue. 
Alternatively, these biologics spare IL-17F, which has been shown to cooperate with IL-17A in promoting 
resistance to OPC [63,78].  Cumulatively, these findings all support a central role for IL-17 receptor signal 
transduction in mucosal host defense, at both innate and adaptive levels.
Conclusion
The epithelial cell plays a fundamental role in the host response to C. albicans (Figure 1).  Both C. albicans 
yeast and hyphae are recognized, but only hyphae are able to invade epithelial cells by induced endocytosis 
and/or active penetration, causing activation of epithelial cells.  Endocytosis of C. albicans is mediated via 
multiple epithelial receptors and the fungal invasin Als3, but epithelial cells are predominantly activated by 
the hypha-associated peptide toxin Candidalysin.  Candidalysin damages epithelial membranes and 
activates danger response pathways mediated via p38/cFos and ERK/MKP1, which results in immune 
activation and the secretion of cytokines and chemokines.  These effector molecules recruit innate immune 
cells such as neutrophils, macrophages and innate Type 17 cells.  Neutrophils (and macrophages) directly 
kill or restrict the fungus through phagocytosis mechanisms and/or NET formation, and innate Type 17 cells 
secrete IL-17 and other inflammatory effectors to further recruit neutrophils and promote mucosal barrier 
function.  These innate immune responses work in conjunction with epithelial cells to control the fungal 
infection.  It is clear that C. albicans hypha formation is critically important for both fungal pathogenicity 
and the host response.  Additional advances into these epithelial-hyphal interaction events will no doubt 
provide valuable insights into our understanding of C. albicans infections in the future.  
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Table 1  C. albicans genes involved  during interactions with epithelial cells






Induces epithelial signalling. Recognised by Epha2.
Induces epithelial signalling. Receptors not identified. 
Induces epithelial signalling. Receptors not identified. 




HWP1 Adhesion to epithelial cells via transglutaminase 
activity. Specific host receptors unknown.
[8]
ALS1-9 Adhesin family. Structural studies indicate this family 
has multiple epithelial targets.
[14,79-82]
INT1 Interaction with epithelial integrins. [83]
Toxins
ECE1 Parent protein of Candidalysin. Induces c-Fos and MKP1 




ALS3 Activation of or interaction with E-cadherin, 
EGFR/Her2, AhR, NEDD9 and PDGF BB
[13,15,16,18•,20•]





SAP1-8 Secreted aspartic proteases – digestion of epithelial 
tissues. Sap5 degrades E-cadherin
[84,85]
PLB1 Phospholipase B1 – digestion of epithelial tissues [86]
LIP1-10 Lipase family – digestion of epithelial tissues [87]
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